These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 27500408)

  • 21. Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt/β-catenin signaling under fully defined conditions.
    Lian X; Zhang J; Azarin SM; Zhu K; Hazeltine LB; Bao X; Hsiao C; Kamp TJ; Palecek SP
    Nat Protoc; 2013 Jan; 8(1):162-75. PubMed ID: 23257984
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of stirred suspension bioreactor culture on the differentiation of murine embryonic stem cells into cardiomyocytes.
    Shafa M; Krawetz R; Zhang Y; Rattner JB; Godollei A; Duff HJ; Rancourt DE
    BMC Cell Biol; 2011 Dec; 12():53. PubMed ID: 22168552
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Purification of cardiomyocytes from differentiating pluripotent stem cells using molecular beacons that target cardiomyocyte-specific mRNA.
    Ban K; Wile B; Kim S; Park HJ; Byun J; Cho KW; Saafir T; Song MK; Yu SP; Wagner M; Bao G; Yoon YS
    Circulation; 2013 Oct; 128(17):1897-909. PubMed ID: 23995537
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bioprocess development for mass production of size-controlled human pluripotent stem cell aggregates in stirred suspension bioreactor.
    Abbasalizadeh S; Larijani MR; Samadian A; Baharvand H
    Tissue Eng Part C Methods; 2012 Nov; 18(11):831-51. PubMed ID: 22559864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Considerations in designing systems for large scale production of human cardiomyocytes from pluripotent stem cells.
    Chen A; Ting S; Seow J; Reuveny S; Oh S
    Stem Cell Res Ther; 2014 Jan; 5(1):12. PubMed ID: 24444355
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Simple Protocol for the Generation of Cardiomyocytes from Human Pluripotent Stem Cells.
    Sequiera GL; Mehta A; Shim W
    Methods Mol Biol; 2016; 1307():379-83. PubMed ID: 24297314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Developing a Cost-Effective and Scalable Production of Human Hepatic Competent Endoderm from Size-Controlled Pluripotent Stem Cell Aggregates.
    Farzaneh Z; Najarasl M; Abbasalizadeh S; Vosough M; Baharvand H
    Stem Cells Dev; 2018 Feb; 27(4):262-274. PubMed ID: 29298619
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Are These Cardiomyocytes? Protocol Development Reveals Impact of Sample Preparation on the Accuracy of Identifying Cardiomyocytes by Flow Cytometry.
    Waas M; Weerasekera R; Kropp EM; Romero-Tejeda M; Poon EN; Boheler KR; Burridge PW; Gundry RL
    Stem Cell Reports; 2019 Feb; 12(2):395-410. PubMed ID: 30686762
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Derivation of highly purified cardiomyocytes from human induced pluripotent stem cells using small molecule-modulated differentiation and subsequent glucose starvation.
    Sharma A; Li G; Rajarajan K; Hamaguchi R; Burridge PW; Wu SM
    J Vis Exp; 2015 Mar; (97):. PubMed ID: 25867738
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclooxygenases Inhibitors Efficiently Induce Cardiomyogenesis in Human Pluripotent Stem Cells.
    Nemade H; Acharya A; Chaudhari U; Nembo E; Nguemo F; Riet N; Abken H; Hescheler J; Papadopoulos S; Sachinidis A
    Cells; 2020 Feb; 9(3):. PubMed ID: 32120775
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Label-free imaging for quality control of cardiomyocyte differentiation.
    Qian T; Heaster TM; Houghtaling AR; Sun K; Samimi K; Skala MC
    Nat Commun; 2021 Jul; 12(1):4580. PubMed ID: 34321477
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Downregulation of LGR5 Expression Inhibits Cardiomyocyte Differentiation and Potentiates Endothelial Differentiation from Human Pluripotent Stem Cells.
    Jha R; Singh M; Wu Q; Gentillon C; Preininger MK; Xu C
    Stem Cell Reports; 2017 Aug; 9(2):513-527. PubMed ID: 28793247
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Universal cardiac induction of human pluripotent stem cells in two and three-dimensional formats: implications for in vitro maturation.
    Zhang M; Schulte JS; Heinick A; Piccini I; Rao J; Quaranta R; Zeuschner D; Malan D; Kim KP; Röpke A; Sasse P; Araúzo-Bravo M; Seebohm G; Schöler H; Fabritz L; Kirchhof P; Müller FU; Greber B
    Stem Cells; 2015 May; 33(5):1456-69. PubMed ID: 25639979
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heparin Promotes Cardiac Differentiation of Human Pluripotent Stem Cells in Chemically Defined Albumin-Free Medium, Enabling Consistent Manufacture of Cardiomyocytes.
    Lin Y; Linask KL; Mallon B; Johnson K; Klein M; Beers J; Xie W; Du Y; Liu C; Lai Y; Zou J; Haigney M; Yang H; Rao M; Chen G
    Stem Cells Transl Med; 2017 Feb; 6(2):527-538. PubMed ID: 28191759
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel Bioreactor Platform for Scalable Cardiomyogenic Differentiation from Pluripotent Stem Cell-Derived Embryoid Bodies.
    Rungarunlert S; Ferreira JN; Dinnyes A
    Methods Mol Biol; 2016; 1502():169-79. PubMed ID: 27044041
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oxygen Is an Ambivalent Factor for the Differentiation of Human Pluripotent Stem Cells in Cardiac 2D Monolayer and 3D Cardiac Spheroids.
    Souidi M; Sleiman Y; Acimovic I; Pribyl J; Charrabi A; Baecker V; Scheuermann V; Pesl M; Jelinkova S; Skladal P; Dvorak P; Lacampagne A; Rotrekl V; Meli AC
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33440843
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Probing flecainide block of I
    Geng L; Kong CW; Wong AOT; Shum AM; Chow MZY; Che H; Zhang C; Yau KL; Chan CW; Keung W; Li RA
    Toxicol Lett; 2018 Sep; 294():61-72. PubMed ID: 29758359
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protein-free media for cardiac differentiation of hPSCs in 2000 mL suspension culture.
    Kriedemann N; Manstein F; Hernandez-Bautista CA; Ullmann K; Triebert W; Franke A; Mertens M; Stein ICAP; Leffler A; Witte M; Askurava T; Fricke V; Gruh I; Piep B; Kowalski K; Kraft T; Zweigerdt R
    Stem Cell Res Ther; 2024 Jul; 15(1):213. PubMed ID: 39020441
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selection of human induced pluripotent stem cells lines optimization of cardiomyocytes differentiation in an integrated suspension microcarrier bioreactor.
    Laco F; Lam AT; Woo TL; Tong G; Ho V; Soong PL; Grishina E; Lin KH; Reuveny S; Oh SK
    Stem Cell Res Ther; 2020 Mar; 11(1):118. PubMed ID: 32183888
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 3D Microwell Platform for Cardiomyocyte Differentiation of Human Pluripotent Stem Cells.
    Branco MA; Dias TP; Cotovio JP; Rodrigues CAV; Fernandes TG; Cabral JMS; Diogo MM
    Methods Mol Biol; 2022; 2454():127-143. PubMed ID: 33145715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.